# Sexuality and Intimacy in Inflammatory Bowel Disease: A Phenomenological Study

**Authors:** Caterina Mercuri, Vincenzo Bosco, Vincenza Giordano, Teresa Rea, Raúl Juárez-Vela, Patrizia Doldo, Silvio Simeone

PMC · DOI: 10.3390/healthcare14040526 · Healthcare · 2026-02-19

## TL;DR

This study explores how inflammatory bowel disease affects people's sexual lives and relationships, revealing emotional and physical challenges that are often ignored in healthcare.

## Contribution

The study provides novel qualitative insights into the lived experiences of IBD patients regarding sexuality and intimacy, highlighting gaps in clinical care.

## Key findings

- IBD significantly impacts sexual health through physical symptoms and emotional distress.
- Stigmatization and body image changes lead to withdrawal from intimacy and feelings of shame.
- Participants expressed a lack of communication with healthcare providers about sexual health concerns.

## Abstract

Background/Objectives: Inflammatory Bowel Disease (IBD) often occurs during early adulthood and substantially affects physical, psychological, and relational well-being. Although sexual health is a fundamental component of quality of life, it is rarely addressed in clinical practice and remains insufficiently explored in research. This study aimed to explore the lived experiences of individuals with IBD regarding sexuality and intimate relationships. Methods: Qualitative phenomenological design was adopted. Nineteen adults with a confirmed diagnosis of Crohn’s disease or Ulcerative Colitis were purposively recruited from a gastroenterology and endoscopy unit of a university hospital in Southern Italy. Data were collected through in-depth, audio-recorded interviews conducted in Italian, transcribed verbatim, and analyzed using Cohen’s phenomenological method. Lincoln and Guba’s criteria were applied to ensure methodological rigor. Results: Five main themes and two subthemes emerged. Participants reported that IBD profoundly affected their sexual lives, not only through physical symptoms but also by eliciting emotional distress and avoidance behaviors. Stigmatization of symptoms such as incontinence and bloating frequently led to withdrawal from physical intimacy. Changes in body image, including weight fluctuations, scarring, and fear of a possible stoma, were associated with feelings of shame and self-alienation. Sexuality was often described as mechanical and emotionally detached, although some participants reported processes of relational reconnection. Concerns about relationship stability and uncertainty about the future were common, alongside a persistent lack of communication with healthcare professionals regarding sexual health. Conclusions: Sexual health in people with IBD is essential yet frequently overlooked. A holistic and empathetic approach that integrates sexual health into routine IBD care may enhance emotional well-being, improve partner communication, and strengthen the overall quality of care.

## Linked entities

- **Diseases:** Inflammatory Bowel Disease (MONDO:0005265), Crohn’s disease (MONDO:0005011), Ulcerative Colitis (MONDO:0005101)

## Full-text entities

- **Genes:** NOD2 (nucleotide binding oligomerization domain containing 2) [NCBI Gene 64127] {aka ACUG, BLAU, BLAUS, CARD15, CD, CLR16.3}, ATG16L1 (autophagy related 16 like 1) [NCBI Gene 55054] {aka APG16L, ATG16A, ATG16L, IBD10, WDR30}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL23R (interleukin 23 receptor) [NCBI Gene 149233] {aka PSORS7}
- **Diseases:** cognitive impairments (MESH:D003072), UC (MESH:D003093), pyoderma gangrenosum (MESH:D017511), acne (MESH:D000152), psoriasis (MESH:D011565), fistulas (MESH:D005402), incontinence (MESH:D014549), stenosis (MESH:D003251), dementia (MESH:D003704), diarrhea (MESH:D003967), fatigue (MESH:D005221), hair loss (MESH:D000505), depression (MESH:D003866), IBD (MESH:D015212), abdominal discomfort (MESH:D000007), Weight gain (MESH:D015430), mood symptoms (MESH:D019964), erectile dysfunction (MESH:D007172), impairments in sexual health (OMIM:603663), anxiety (MESH:D001007), flatulence (MESH:D005414), vitamin deficiencies (MESH:D014802), abdominal pain (MESH:D015746), weight loss (MESH:D015431), sexual dysfunction (MESH:D012735), sexual (MESH:D050035), acneiform eruptions (MESH:D017486), CD (MESH:D003424), psychiatric disorders (MESH:D001523), infections (MESH:D007239), colorectal cancer (MESH:D015179), skin (MESH:D012871), quality (MESH:D012893), pain (MESH:D010146), loss (MESH:D016388), anemia (MESH:D000740), injury to (MESH:D014947), damn disease (MESH:D004194), erythema nodosum (MESH:D004893), inflammation (MESH:D007249)
- **Chemicals:** methotrexate (MESH:D008727), steroids (MESH:D013256), 6-mercaptopurine (MESH:D015122), azathioprine (MESH:D001379), thiopurines (MESH:C520399)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941028/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12941028/full.md

## References

112 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941028/full.md

---
Source: https://tomesphere.com/paper/PMC12941028